Skip to main navigation Skip to search Skip to main content

'Do I actually even need all these tablets?' A qualitative study exploring deprescribing decision-making for people in receipt of palliative care and their family members

  • Anna Robinson-Barella
  • , Charlotte Lucy Richardson
  • , Zana Bayley
  • , Andy Husband
  • , Rona Bojke
  • , Andy Bojke
  • , Rachel Quibell
  • , Lisa Baker
  • , Emma McDougall
  • , Catherine Exley
  • , Barbara Hanratty
  • , Joanna Elverson
  • , Jesse Jansen
  • , Adam Todd*
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Background: For people in receipt of palliative care, where polypharmacy is common and medication burden is high, there remains limited knowledge around the decision-making processes that underpin deprescribing; for example, recent deprescribing studies have focused on wider issues of identifying polypharmacy in palliative care contexts. However, little is known about the specific challenges of, and preferences towards, decision-making to support the deprescribing for people in receipt of palliative care.Aim: To explore decision-making processes that underpin deprescribing approaches, based on the experiences of people in receipt of palliative care, and their family member(s).Design: An explorative qualitative study involving in-person semi-structured interviews, analysed using reflexive thematic analysis.Setting/participants: Twenty-five semi-structured interviews were conducted with people in receipt of palliative care (n = 25), where 12 of these interviews were undertaken as dyads, with both the patient and a family member together. Interviews were undertaken across a range of settings, spanning: hospice outpatient day units (n = 11), hospice inpatient wards (n = 4), care home (n = 1) and patients' own homes (n = 9), and involved people with diverse diagnoses (including: cancer 52%, heart failure 20%, motor neurone disease 12%, pulmonary fibrosis 4% and chronic obstructive pulmonary disease 4%).Results: Two overarching themes were developed - the first reflected the need to address patient understanding by 'laying the foundations of deprescribing decision-making'. The second theme, 'having a voice in deprescribing decision-making', reflected desires to (pro)-actively involve patients and their family member(s) within these processes.Conclusion: There is a need to take a balanced, person-centred and shared approach to deprescribing decision-making for people receiving palliative care. Co-design strategies offer one approach to further explore this.
Original languageEnglish
Pages (from-to)543-552
Number of pages10
JournalPalliative Medicine
Volume39
Issue number5
Early online date1 Apr 2025
DOIs
Publication statusPublished - May 2025

Keywords

  • Deprescriptions
  • palliative care
  • medication review
  • qualitative research
  • OLDER-ADULTS
  • HEALTH-CARE
  • FOCUS GROUP
  • POLYPHARMACY
  • MEDICATIONS
  • PATIENT
  • ATTITUDES
  • END

Fingerprint

Dive into the research topics of ''Do I actually even need all these tablets?' A qualitative study exploring deprescribing decision-making for people in receipt of palliative care and their family members'. Together they form a unique fingerprint.

Cite this